AS
MYOV

Altshuler Shaham’s Myovant Sciences Ltd. MYOV Stock Holding History

Altshuler Shaham’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-46,219
Closed -$1.04M – 688
2021
Q3 		$1.04M Buy
+46,219
New +$1.01M 0.01% 160

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Altshuler Shaham's MYOV Position: Q4 2021 in Review

Altshuler Shaham sold out of Myovant Sciences Ltd. (MYOV) in Q4 2021, closing a stake of 46,219 shares — an estimated $1.04M sold.

Altshuler Shaham first reported a position in MYOV in Q3 2021 and held it in 1 quarter. The position peaked at $1.04M in Q3 2021. 110 funds tracked by Wall St. Rank hold MYOV as of Q4 2021.

  • Altshuler Shaham reported no remaining Myovant Sciences Ltd. position as of Q4 2021 after selling out during the quarter.
  • Altshuler Shaham sold 46,219 Myovant Sciences Ltd. shares in Q4 2021, an estimated $1.04M.
  • Altshuler Shaham first reported a position in Myovant Sciences Ltd. in Q3 2021 and held it in 1 quarter.
  • Altshuler Shaham's Myovant Sciences Ltd. position peaked at $1.04M in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2021.

Based on Altshuler Shaham's 13F filing for Q4 2021, filed 15 Feb 2022.